Global Anti-infective Agents Market Growth 2023-2029

Global Anti-infective Agents Market Growth 2023-2029

Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.

LPI (LP Information)' newest research report, the “Anti-infective Agents Industry Forecast” looks at past sales and reviews total world Anti-infective Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-infective Agents sales for 2023 through 2029. With Anti-infective Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-infective Agents industry.

This Insight Report provides a comprehensive analysis of the global Anti-infective Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-infective Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-infective Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-infective Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-infective Agents.

The global Anti-infective Agents market size is projected to grow from US$ 122910 million in 2022 to US$ 165660 million in 2029; it is expected to grow at a CAGR of 165660 from 2023 to 2029.

North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.

Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infective Agents market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs

Segmentation by application
Hospital Use
Clinic Use
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-infective Agents market?

What factors are driving Anti-infective Agents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-infective Agents market opportunities vary by end market size?

How does Anti-infective Agents break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.